Our in vivo tumor studies indicate that with increasing Myc expression there is greater sensitivity to DON-induced apoptosis while cells that do not overexpress Myc are resistant to cell death from inhibition of glutamine metabolism. The gene discussed is MYC; the disease is neoplasm.